Management of late distant metastases after trimodality therapy for esophageal cancer.
Trimodality therapy has been shown in preliminary studies to increase survival in esophageal cancer. Distant recurrence remains the main pattern of failure. A case of aggressive treatment of two metachronous solitary visceral metastases is presented.
Mao
You Sheng
YS
Division of Thoracic Surgery, University of Maryland Medical System, Baltimore, Maryland, USA.
Suntharalingam
Mohan
M
Krasna
Mark J
MJ
D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary* / Q000628:therapy*; D001707:Biopsy, Needle; D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D002531:Cerebellum / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000628:therapy*; D016629:Esophagectomy / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome